“…To assess all of these current risk factors, several biomarkers are currently being evaluated for their reliability in accurately diagnosing the stages of HAND 13 . Biomarkers for immune activation include elevated plasma and CSF levels of sCD163, sCD14, interleukin (IL)-1α, tumor necrosis factor α (TNFα), MMP2, MCP1, osteopontin, and fractalkine 14,15 . Additional CSF biomarkers for HAND include molecules involved in cellular metabolisms, such as CSF TCA cycle substrates, fatty acids, and triglycerides 5,10,16 .…”